Published in Microvasc Res on July 01, 1977
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol (2003) 12.96
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Emergent patterns of growth controlled by multicellular form and mechanics. Proc Natl Acad Sci U S A (2005) 5.22
Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol (1989) 4.85
Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol (1989) 4.57
Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol (1995) 4.37
Tumors as organs: complex tissues that interface with the entire organism. Dev Cell (2010) 3.98
Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol (1987) 3.72
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain (2010) 3.53
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest (1994) 3.51
Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A (1986) 3.42
Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol (2006) 2.57
Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci U S A (1985) 2.50
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A (2000) 2.47
Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc Natl Acad Sci U S A (2006) 2.41
Control of intracellular pH and growth by fibronectin in capillary endothelial cells. J Cell Biol (1990) 2.41
Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol (1982) 2.33
Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med (1980) 2.27
Macrophage roles following myocardial infarction. Int J Cardiol (2008) 2.14
Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol (1990) 2.09
Can cancer be reversed by engineering the tumor microenvironment? Semin Cancer Biol (2008) 2.07
In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol (1989) 2.05
Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature (2015) 2.01
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol (1990) 2.00
Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol (2007) 1.99
Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol (1986) 1.94
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys (2009) 1.91
Tensegrity-based mechanosensing from macro to micro. Prog Biophys Mol Biol (2008) 1.90
Programmed translational readthrough generates antiangiogenic VEGF-Ax. Cell (2014) 1.90
PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol (1994) 1.85
TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. Circ Res (2009) 1.84
Generation of functional blood vessels from a single c-kit+ adult vascular endothelial stem cell. PLoS Biol (2012) 1.79
The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol (2002) 1.75
A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. Biophys J (2007) 1.74
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest (1998) 1.72
Between molecules and morphology. Extracellular matrix and creation of vascular form. Am J Pathol (1995) 1.72
A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell (2010) 1.72
Transient functional expression of alphaVbeta 3 on vascular cells during wound repair. Am J Pathol (1996) 1.67
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis (1992) 1.65
Endothelial-cell proliferation in experimental tumours. Br J Cancer (1982) 1.63
VEGF and endothelial guidance in angiogenic sprouting. Organogenesis (2008) 1.63
Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol (1991) 1.63
Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann Surg (1982) 1.62
Differentiation-dependent stimulation of neovascularization and endothelial cell chemotaxis by 3T3 adipocytes. Proc Natl Acad Sci U S A (1982) 1.58
Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med (2009) 1.58
Vascular endothelial growth factor and ocular neovascularization. Am J Pathol (1997) 1.56
Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol (2003) 1.55
Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells. BMC Cell Biol (2005) 1.52
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol (1992) 1.51
Mathematical modeling of tumor-induced angiogenesis. J Math Biol (2004) 1.51
Isolation of a nonmitogenic angiogenesis factor from wound fluid. Proc Natl Acad Sci U S A (1982) 1.50
Vascular morphogenesis and remodeling in a human tumor xenograft: blood vessel formation and growth after ovariectomy and tumor implantation. Circ Res (2001) 1.50
Mechanical control of tissue growth: function follows form. Proc Natl Acad Sci U S A (2005) 1.48
Bartonella bacilliformis stimulates endothelial cells in vitro and is angiogenic in vivo. Am J Pathol (1990) 1.48
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J (2000) 1.43
Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci U S A (1983) 1.42
The Vital Role of Blood Flow-Induced Proliferation and Migration in Capillary Network Formation in a Multiscale Model of Angiogenesis. PLoS One (2015) 1.41
Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Am J Pathol (1986) 1.41
Tipping the balance: robustness of tip cell selection, migration and fusion in angiogenesis. PLoS Comput Biol (2009) 1.40
Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci U S A (1991) 1.40
Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am J Pathol (2004) 1.39
Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol (2002) 1.38
Angiogenesis. Cold Spring Harb Perspect Biol (2011) 1.37
Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Cancer Metastasis Rev (2010) 1.36
Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci U S A (1995) 1.35
Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol (1987) 1.35
Potent stimulation of vascular endothelial cell growth by differentiated 3T3 adipocytes. Proc Natl Acad Sci U S A (1980) 1.34
alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells. Mol Biol Cell (1997) 1.33
GIV/Girdin is a rheostat that fine-tunes growth factor signals during tumor progression. Cell Adh Migr (2011) 1.31
Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am J Pathol (1990) 1.29
Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol (1996) 1.26
The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. J Clin Invest (2005) 1.26
Identification of a Ca2(+)-dependent cell-cell adhesion molecule in endothelial cells. J Cell Biol (1990) 1.24
In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci U S A (1992) 1.23
Topography of extracellular matrix mediates vascular morphogenesis and migration speeds in angiogenesis. PLoS Comput Biol (2009) 1.23
Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis (1991) 1.20
EET signaling in cancer. Cancer Metastasis Rev (2011) 1.18
Modulating the tumor microenvironment to increase radiation responsiveness. Cancer Biol Ther (2009) 1.18
Vascular targeted therapies in oncology. Cell Tissue Res (2008) 1.12
Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol (1993) 1.12
Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest (1996) 1.09
Looking for the Word "Angiogenesis" in the History of Health Sciences: From Ancient Times to the First Decades of the Twentieth Century. World J Surg (2017) 1.06
Protein kinase C activators suppress stimulation of capillary endothelial cell growth by angiogenic endothelial mitogens. J Cell Biol (1987) 1.06
Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells. PLoS One (2013) 1.05
Stimulation by a low-molecular-weight angiogenic factor of capillary endothelial cells in culture. Br J Cancer (1980) 1.03
Tumor-immune interaction, surgical treatment, and cancer recurrence in a mathematical model of melanoma. PLoS Comput Biol (2009) 1.02
Understanding vascular development. Wiley Interdiscip Rev Dev Biol (2012) 1.02
Ultrasound assessment of angiogenesis in a matrigel model in rats. Ultrasound Med Biol (2006) 1.02
Therapeutic angiogenesis in cardiovascular disease. J Cardiothorac Surg (2007) 1.01
Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. Am J Pathol (1995) 1.01
Mechanism of a flow-gated angiogenesis switch: early signaling events at cell-matrix and cell-cell junctions. Integr Biol (Camb) (2012) 1.00
Identification and partial characterization of angiogenesis bioactivity in the lower respiratory tract after acute lung injury. J Clin Invest (1991) 1.00
Characterizing the tumor response to treatment with combretastatin A4 phosphate. Int J Radiat Oncol Biol Phys (2007) 1.00
Proteoglycans in the microvascular. II. Histochemical localization in proliferating capillaries of the rabbit cornea. Am J Pathol (1981) 0.99
Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity. Br J Cancer (1992) 0.99
Morphological aspects of angiogenesis in experimental liver metastases. Am J Pathol (1993) 0.98
Ultrastructure of cerebellar capillary hemangioblastoma. IV. Pericytes and their relationship to endothelial cells. Acta Neuropathol (1985) 0.98
Angiogenesis and vasculogenesis in treatment of cardiovascular disease. Mol Med (1998) 0.97
Microfluidic platforms for mechanobiology. Lab Chip (2013) 0.97
Neovascularisation and its role in the osteoarthritic process. Ann Rheum Dis (1988) 0.96
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Angiogenic factors. Science (1987) 15.22
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 13.76
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41
Role of cell shape in growth control. Nature (1978) 12.46
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst (1992) 8.69
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (1997) 7.66
Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med (1995) 7.37
Isolation of a tumor factor responsible for angiogenesis. J Exp Med (1971) 7.12
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol (1993) 6.55
Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A (1994) 6.48
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res (2000) 6.42
Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol (1974) 5.95
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol (1994) 5.76
Long-term culture of capillary endothelial cells. Proc Natl Acad Sci U S A (1979) 5.70
Tumor angiogenesis. Adv Cancer Res (1985) 5.66
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (1990) 5.15
Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science (1999) 4.91
Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol (1989) 4.85
Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A (1987) 4.83
Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med (1992) 4.76
Angiogenesis in vitro. Nature (1980) 4.46
Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg (1972) 4.37
Tumor dormancy in vivo by prevention of neovascularization. J Exp Med (1972) 4.34
Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science (1984) 4.27
Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst (1974) 4.05
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol (1994) 3.76
Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med (1996) 3.64
Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst (1995) 3.53
Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation (1999) 3.53
A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci (1996) 3.49
Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol (1976) 3.21
Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg (1966) 3.00
Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest (1994) 2.97
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol (1996) 2.95
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A (1997) 2.88
Self-regulation of growth in three dimensions. J Exp Med (1973) 2.87
How does extracellular matrix control capillary morphogenesis? Cell (1989) 2.84
Polymers for the sustained release of proteins and other macromolecules. Nature (1976) 2.81
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci U S A (2001) 2.81
Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest (1993) 2.71
How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res (1986) 2.69
Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res (1999) 2.58
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun (1993) 2.56
Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell (1991) 2.52
Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst (1972) 2.52
Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst (1994) 2.50
Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry (1989) 2.49
Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood (1999) 2.49
Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science (1983) 2.47
A simple procedure for the long-term cultivation of chicken embryos. Dev Biol (1974) 2.46
Tumor angiogenesis. Adv Cancer Res (1974) 2.38
Protamine is an inhibitor of angiogenesis. Nature (1982) 2.30
Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med (1980) 2.27
Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell (1998) 2.17
Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature (1969) 2.16
Fine structure of vascular endothelium in culture. J Ultrastruct Res (1975) 2.15
Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics (1999) 2.12
Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. J Natl Cancer Inst (2001) 2.10
Betacellulin: a mitogen from pancreatic beta cell tumors. Science (1993) 2.10
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Natl Acad Sci U S A (1996) 2.07
Involvement of platelets in tumour angiogenesis? Lancet (1998) 2.03
Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol (1997) 1.98
Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors. J Natl Cancer Inst (1973) 1.95
Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr (1998) 1.95
Isolation and characterization of endothelial progenitor cells from mouse embryos. Development (1998) 1.94
Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Dev Biol (1987) 1.93
Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet (1981) 1.92
Proceedings: Tumor angiogenesis factor. Cancer Res (1974) 1.86
Influence of geometry on control of cell growth. Biochim Biophys Acta (1975) 1.79
Isolations of a cartilage factor that inhibits tumor neovascularization. Science (1976) 1.79
Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem (1999) 1.78
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med (1995) 1.78
Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. J Cell Biochem (1985) 1.77
Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels. Am J Pathol (1975) 1.77
The hemostatic system as a regulator of angiogenesis. J Biol Chem (2000) 1.76
Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med (1975) 1.74
Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol (1994) 1.73
Tumor angiogenesis. Rapid induction of endothelial mitoses demonstrated by autoradiography. J Cell Biol (1972) 1.72
Mast cells and tumor angiogenesis. Int J Cancer (1976) 1.71
Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun (1991) 1.67
Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science (1999) 1.67
Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci U S A (1998) 1.66
In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest (1996) 1.65
Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res (2001) 1.64
Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem (1996) 1.63
Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol (1998) 1.60
Tumor angiogenesis: a possible control point in tumor growth. Ann Intern Med (1975) 1.60
Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer (1994) 1.60
Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest (1988) 1.58
Angiogenesis: initiation and control. Ann N Y Acad Sci (1982) 1.57
Angiogenesis and breast cancer. J Clin Oncol (1994) 1.56
Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res (2001) 1.55
A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology (1986) 1.55
The vascularization of tumors. Sci Am (1976) 1.51